a New York University School of Medicine , New York USA.
b Department of Population Health , New York University School of Medicine , New York.
Subst Use Misuse. 2019;54(7):1138-1145. doi: 10.1080/10826084.2018.1563186. Epub 2019 Feb 1.
Cigarette smoking and chronic pain are prevalent, comorbid conditions with significant consequences for individuals and society. Despite overlap between smoking and chronic pain, and pain's role as a potential barrier to quitting, there are no validated interventions targeted for smokers with chronic pains (SWCPs).
To compare characteristics of urban inpatient smokers with and without chronic pain to inform the development of SWCP-targeted cessation interventions.
This study reports partial results from a randomized comparative effectiveness trial of two smoking cessation interventions (NCT01363245). Participants were enrolled at two safety net hospitals in New York, NY in 2011-2014. Data were collected from the electronic health record and an interviewer-administered survey. Participants were considered to have chronic pain if they affirmed having "long-lasting, persistent, or chronic pain in the last six months" on survey.
Among smokers assessed for pain (n = 1093), the prevalence of chronic pain was 44%. SWCPs were more likely to report depressive symptoms and to have a history of psychiatric diagnosis (nonsubstance related) than smokers without pain. Severe problems with mobility and with performing usual activities were more common in SWCPs. No significant difference was observed in sex, race, education, nicotine dependence level, confidence in quit ability, or history of substance misuse. Conclusions/Importance: Chronic pain in smokers admitted to safety net hospitals is prevalent and associated with hindered mobility, history of psychiatric diagnosis, and prescription opioid use. Urban safety net hospitals are an appropriate setting in which to pilot SWCP-targeted cessation programs, which should be designed with consideration for patients' psychiatric history and mobility status.
吸烟和慢性疼痛是普遍存在的、共病的情况,对个人和社会都有重大影响。尽管吸烟和慢性疼痛存在重叠,且疼痛可能成为戒烟的障碍,但目前还没有针对患有慢性疼痛的吸烟者(SWCP)的有效干预措施。
比较有和无慢性疼痛的城市住院吸烟者的特征,为开发针对 SWCP 的戒烟干预措施提供信息。
本研究报告了一项针对两种戒烟干预措施的随机对照效果试验的部分结果(NCT01363245)。参与者于 2011 年至 2014 年在纽约市的两家医疗保障医院中入选。数据来自电子健康记录和访谈者管理的调查。如果参与者在调查中确认“过去六个月中存在持续、持久或慢性疼痛”,则被认为患有慢性疼痛。
在接受疼痛评估的吸烟者中(n=1093),慢性疼痛的患病率为 44%。SWCP 更有可能报告抑郁症状,并有非物质相关的精神疾病诊断史,而无疼痛的吸烟者则没有这些症状。SWCP 在行动和进行日常活动方面存在严重问题的比例更高。在性别、种族、教育程度、尼古丁依赖水平、戒烟能力信心或物质滥用史方面,两组之间没有观察到显著差异。
结论/意义:在被收入医疗保障医院的吸烟者中,慢性疼痛较为普遍,且与行动受限、精神疾病诊断史和处方类阿片药物使用有关。城市医疗保障医院是试点针对 SWCP 的戒烟计划的合适场所,应考虑患者的精神病史和行动能力来设计这些计划。